RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

July 7, 2023

Study Completion Date

May 6, 2024

Conditions
Carbon Dioxide LaserPhotoaging
Interventions
DRUG

ReCell

"The perioral area of the face will be treated with CO2 laser. Randomization would occur before study initiation with subjects assigned either left perioral or right perioral RECELL treatment based on their subject enrollment number. The study team member who prepares and blinds the RECELL will create the list of subject ID numbers with subject ID number randomly assigned to either left perioral or right perioral treatment group. This will be completed prior to any patient enrollment in the study. Intraoperatively, RECELL and Placebo will be provided to surgeons and assistants in opaque application devices prepared by a trained, designated study team member.~Both the treatment and placebo sides, will be dressed with a standard autologous cell suspension post treatment dressing (Telfa Clear and Xeroform)."

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Avita Medical

INDUSTRY

lead

Wake Forest University Health Sciences

OTHER

NCT05386368 - RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients | Biotech Hunter | Biotech Hunter